Hege Marie Thoresen

  • Citations Per Year
Learn More
Axitinib is a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 1 (VEGFR-1), VEGFR-2, and VEGFR-3. Based on the positive opinion from the European Medicines Agency (EMA), a marketing authorization valid throughout the European Union (EU) was issued for the treatment of advanced renal cell carcinoma (RCC) after failure of prior(More)
In 2009 a new price system for the produced power was introduced for Norwegian hydro power plants. Basically a power producer gets punished if his production deviates from the scheduled production. The power plant is paid for the actual production: if too much power is produced that the price for the excess power is low. Even worse if too little power is(More)
  • 1